Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy
Conventional approaches for antiparasitic drug discovery center upon discovering selective agents that adversely impact parasites with minimal host side effects. Here, we show that agents with a broad polypharmacology, often considered ‘dirtier’ drugs, can have unique efficacy if they combine delete...
Main Authors: | John D Chan, Timothy A Day, Jonathan S Marchant |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2018-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/35755 |
Similar Items
-
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
by: Andrea Angeli, et al.
Published: (2022-12-01) -
The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets
by: Vinícius Roquini, et al.
Published: (2023-08-01) -
TRP drop, TRP drop: a steady patter of anti-schistosomal target illumination
by: Daniel J. Sprague, et al.
Published: (2024-02-01) -
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities
by: Sebastian Walesch, et al.
Published: (2024-03-01) -
A bacterial artificial chromosome library for Biomphalaria glabrata, intermediate snail host of Schistosoma mansoni
by: Coen M Adema, et al.
Published: (2006-10-01)